Epocrates, Inc., a leading provider of clinical decision support tools, is headquartered in the United States. Founded in 1998, the company has established itself as a vital resource for healthcare professionals, offering innovative solutions that enhance patient care and streamline clinical workflows. With a focus on mobile applications and web-based platforms, Epocrates delivers essential drug information, disease diagnosis, and treatment guidelines, making it a trusted companion for physicians and pharmacists alike. Its flagship product, the Epocrates app, is renowned for its user-friendly interface and comprehensive database, setting it apart in the competitive healthcare technology landscape. Recognised for its commitment to improving clinical outcomes, Epocrates has garnered a significant market position, serving millions of healthcare providers across North America and beyond. The company continues to evolve, integrating the latest medical research and technology to support informed decision-making in the ever-changing healthcare environment.
How does Epocrates, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Epocrates, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Epocrates, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Epocrates, Inc. may inherit climate commitments and emissions data from its parent organisation; however, no specific details have been provided regarding such cascaded information. The lack of emissions data and reduction initiatives suggests that Epocrates, Inc. has yet to establish a formalised approach to addressing its carbon footprint or climate impact. In the broader context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives, which may influence Epocrates, Inc. to develop its own commitments in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Epocrates, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
